Hematopoietic stem cell transplant-related airflow obstruction

Area of Science:

• Pulmonary Medicine
• Hematology
• Transplantation Immunology

Background:

• Airflow obstruction is a rare, fatal complication post-allogeneic hematopoietic stem cell transplantation.
• This condition, often termed bronchiolitis obliterans, primarily affects small airways and can lead to their obliteration.
• It is a noninfectious, late-onset complication.

Purpose of the Study:

• To review recent literature on the progress in understanding and managing airflow obstruction after hematopoietic stem cell transplantation.
• To evaluate advancements in diagnosis and treatment of bronchiolitis obliterans.

Main Methods:

• Literature review of recently published studies.
• Analysis of reported pulmonary function test (PFT) results and follow-up data.
• Evaluation of findings from high-resolution computed tomography (HRCT).

Main Results:

• Changes in PFTs may aid in earlier detection and management of bronchiolitis obliterans.
• Graft-versus-host disease is a potential underlying cause of this complication.
• HRCT findings can assist in diagnosis; anti-inflammatory therapy, azithromycin, and lung transplantation are potential treatment options.

Conclusions:

• The exact pathomechanism of bronchiolitis obliterans post-hematopoietic stem cell transplantation remains unclear.
• Effective management requires a better understanding of the disease, consensus diagnostic criteria, and prospective treatment trials.
• Bronchiolitis obliterans remains a significant challenge and a fatal complication.